Aemilia Katzinski

Aemilia Katzinski is a seasoned professional in the biotechnology and pharmaceuticals industry with extensive experience in cell therapy and laboratory operations. Currently serving as a Manufacturing Associate II at CTMC, a joint venture between Resilience and MD Anderson Cancer Center since October 2022, Aemilia previously held positions as Cell Therapy Specialist II and Cell Therapy Specialist I at Catalent Pharma Solutions from August 2021 to October 2022. Prior experience includes working as a Laboratory Technician at Oxford BioDynamics Plc from March 2020 to August 2021. Aemilia holds a Bachelor of Science degree in Biomedical Sciences from Oxford Brookes University.